BioActor   Report issue

For profit Phase 2
Founded: Maastricht Netherlands (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2008
NCT00789425
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bioactor | BioActor | BioActor B.V.